Fluoxetine, sold under the brand name Prozac, among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is used...
119 KB (11,703 words) - 10:40, 13 June 2024
Olanzapine/fluoxetine (trade name Symbyax, created by Eli Lilly and Company) is a fixed-dose combination medication containing olanzapine (Zyprexa), an...
8 KB (537 words) - 23:59, 27 January 2024
licensing of four newer antidepressants (including the SSRIs paroxetine and fluoxetine, the non-SSRI antidepressant nefazodone, and the serotonin and norepinephrine...
127 KB (13,891 words) - 15:33, 19 July 2024
compound later named fluoxetine to be the most potent and selective inhibitor of serotonin reuptake of the series. Introduction of fluoxetine to the market is...
51 KB (5,339 words) - 15:16, 11 April 2024
(statistically significant), as compared to no treatment. At the same time, fluoxetine (Prozac) halved the suicide risk. In a study sponsored by Wyeth, which...
68 KB (6,419 words) - 19:57, 2 July 2024
clomipramine has again been found to be effective, fluoxetine has not produced consistent positive results. Fluoxetine, however, has produced positive results in...
18 KB (2,083 words) - 03:29, 16 October 2023
also markets olanzapine in a fixed-dose combination with fluoxetine as olanzapine/fluoxetine (Symbyax). It is on the World Health Organization's List...
92 KB (8,663 words) - 12:40, 14 July 2024
antidepressant fluoxetine; it is nearly 4 times more selective for stimulating neurosteroid synthesis relative to serotonin reuptake inhibition than fluoxetine. It...
5 KB (449 words) - 19:47, 29 April 2024
adolescents with moderate to severe depressive disorder, some evidence suggests fluoxetine (either with or without cognitive behavioral therapy) is the best treatment...
191 KB (20,463 words) - 23:56, 20 July 2024
in the pediatric population though remains a second line therapy after fluoxetine. In general, sertraline efficacy is similar to that of other antidepressants...
101 KB (10,398 words) - 03:21, 19 July 2024